Celltrion Pharm, Inc., a pharmaceutical company, develops and sells biosimilars and over-the-counter drugs in South Korea. The company offers hepatotonic, anti-inflammatory, antihistamine, respiratory apparatus, circulary system, digestive and stomachic, hormone/metabolic disease, antibiotic/antimycotic, nutrientia and tonic, immunology, oncology, and other drugs. It serves university hospitals and general pharmacies. Celltrion Pharm Inc. was founded in 1976 and is based in Cheongju-si, South Korea. Celltrion Pharm, Inc. (KOSDAQ:A068760) operates as a subsidiary of Celltrion, Inc.
The current price of 068760.KQ is ₩47,000 KRW — it has decreased by -4.37% in the past 24 hours. Watch Celltrion Pharm stock price performance more closely on the chart.
What is Celltrion Pharm stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Celltrion Pharm stocks are traded under the ticker 068760.KQ.
Is Celltrion Pharm stock price growing?▼
068760.KQ stock has fallen by -8.56% compared to the previous week, the month change is a -18.97% fall, over the last year Celltrion Pharm has showed a +0.75% increase.
What is Celltrion Pharm market cap?▼
Today Celltrion Pharm has the market capitalization of 2.04T
What is Celltrion Pharm revenue for the last year?▼
Celltrion Pharm revenue for the last year amounts to 955.67B KRW.
What is Celltrion Pharm net income for the last year?▼
068760.KQ net income for the last year is 43.93B KRW.
Does Celltrion Pharm pay dividends?▼
Yes, 068760.KQ dividends are paid en. The last dividend per share was 200 KRW. As of today, Dividend Yield (FWD)% is 0.41%.
In which sector is Celltrion Pharm located?▼
Celltrion Pharm operates in the Health & Wellness sector.
When did Celltrion Pharm complete a stock split?▼
The last stock split for Celltrion Pharm was on December 27, 2024 with a ratio of 1.05:1.
Where is Celltrion Pharm headquartered?▼
Celltrion Pharm is headquartered in Cheongju-si, South Korea.